Atlas Trials

Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension

Clinical trial NCT06917131 · RECRUITING

Trial details

NCT number
NCT06917131
Sponsor
Universidade Federal Fluminense
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
HypertensionCardiovascular Diseases (CVD)Inflammation
Start date
2024-09-18
Primary completion
2026-12-10
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.